The Rosner–Colditz breast cancer incidence model provides prediction of subtypes based on ER and PR only, with poorer performance for ER/PR − (AUC = 0.598) disease than ER/PR + (AUC = 0.629) disease [13]. This evidence concerns the gene ESR1 and breast carcinoma.